Showing results (171-180 of 318) with videos related to

Sort By:
Pageof 32
Future Oncology (London, England)|June 22, 2016
A Phase II study of olaparib in breast cancer patients: biological evaluation from a 'window of opportunity' trialGiandomenico Roviello, Manuela Milani, Angela Gobbi, et al.
Breast Cancer Research and Treatment|November 3, 2021
Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysisFrancesca Poggio, Lucia Del Mastro, Marco Bruzzone, et al.
Cancer Treatment Reviews|December 24, 2013
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trialsLucia Del Mastro, Marcello Ceppi, Francesca Poggio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancerDaniele Generali, Stephen B Fox, Alfredo Berruti, et al.
Annals of Surgical Oncology|September 12, 2012
Comparison of molecular subtyping with BluePrint, MammaPrint, and TargetPrint to local clinical subtyping in breast cancer patientsBichlien Nguyen, Pino G Cusumano, Kenneth Deck, et al.
Oncotarget|June 7, 2018
Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenograftsFederica Guffanti, Maddalena Fratelli, Monica Ganzinelli, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 27, 2015
Breast cancer circulating biomarkers: advantages, drawbacks, and new insightsAndrea Ravelli, James M Reuben, Francesco Lanza, et al.
European Journal of Endocrinology|December 23, 2011
Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinomaAlfredo Berruti, Paola Sperone, Anna Ferrero, et al.
The Oncologist|December 14, 2024
Identifying the best treatment choice for relapsing/refractory glioblastoma: a systematic review with multiple Bayesian network meta-analysesFrancesco Schettini, Estela Pineda, Andrea Rocca, et al.
Cancer Treatment Reviews|December 20, 2023
Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug conjugates (ADCs)Arianna Dri, Grazia Arpino, Giampaolo Bianchini, et al.
Pageof 32